Angela Bagley
Chief Tech/Sci/R&D Officer chez TREVENA, INC.
Profil
Angela Bagley is currently the Vice President-Technical Operations at Trevena, Inc. Prior to her current position, she held the role of Global Head-Pharmaceutical at Bristol Myers Squibb Co. She also served as the VP-Global Supply Chain Planning & Logistics at Celgene Corp.
and as the Head-Supply Chain & Process Engineering at Merck & Co., Inc. Ms. Bagley completed her undergraduate degree at North Carolina State University.
Postes actifs de Angela Bagley
| Sociétés | Poste | Début |
|---|---|---|
| TREVENA, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Angela Bagley
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| CELGENE | Corporate Officer/Principal | - |
Formation de Angela Bagley
| North Carolina State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| TREVENA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
